TELO实时信号 | 通过Getagraph.com最大化利润

出售 123309 min ago

@ $8.43

发出时间: 15 Feb 2024 @ 01:26

回报率: -22.42%

Live Chart Being Loaded With Signals

Commentary (10 May 2024 @ 04:00):

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells...

Stats
今日成交量	73 128.00
平均成交量	60 519.00
市值	193.65M
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	0
ATR14	$0.0510 (0.78%)

音量相关性

長: 0.21 (neutral)

短: -0.18 (neutral)

Signal:(60.915) Neutral

Telomir Pharmaceuticals, 相关性

10 最正相关

10 最负相关

你知道吗？

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1，其中-1表示完全负相关（一个变量增加，另一个变量减少），1表示完全正相关（一个变量增加，另一个变量也增加），0表示没有相关性（变量之间没有关系）。

相关性可用于分析任何两个变量之间的关系，而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

Telomir Pharmaceuticals, 相关性 - 货币/商品

-0.21
( neutral )

-0.27
( neutral )

0.00
( neutral )

0.23
( neutral )

-0.33
( neutral )

0.02
( neutral )

Financial Reports:

No articles found.

Telomir Pharmaceuticals,

Telomir Pharmaceuticals, Inc., a pre-clinical-stage pharmaceutical company, focuses on the development and commercialization of therapeutic treatment for human stem cells. It develops TELOMIR-1, a novel small molecule being developed to function as an oral in situ therapeutic intervention against age-related inflammatory conditions, such as hemochromatosis and osteoarthritis, as well as for post-chemotherapy recovery by interrupting and preventing the interleukin-17 induced inflammatory pathways. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc. on October 10, 2022. Telomir Pharmaceuticals, Inc. was incorporated in 2021 and is headquartered in Baltimore, Maryland.